Enrocare 50g/100ml Solution for Injection 100ml

Enrocare 50 mg/100ml Solution Injection for Cattle, Pigs, Dogs & Cats.

Cattle
Diseases of the respiratory and alimentary tract of bacterial or mycoplasmal origin (e.g. pasteurellosis, mycoplasmosis, coli-bacillosis, coli-septicaemia and salmonellosis) and secondary bacterial infections subsequent to viral conditions (e.g. viral pneumonia), where clinical experience, supported where possible by sensitivity testing of the causal organism, indicates enrofloxacin as the drug of choice.

Pigs (weighing more than 25 kg)
Diseases of the respiratory and alimentary tract of bacterial or mycoplasmal origin (e.g. pasteurellosis, actinobacillosis, mycoplasmosis, coli-bacillosis, coli-septicaemia and salmonellosis) and multifactorial diseases such as atrophic rhinitis and enzootic pneumonia, where clinical experience, supported where possible by sensitivity testing of the causal organism, indicates enrofloxacin as the drug of choice.

Dogs and cats
Treatment of bacterial infections of the alimentary, respiratory and urogenital tracts, skin, secondary wound infections and otitis externa where clinical experience, supported where possible by sensitivity testing of the causal organism, indicates enrofloxacin as the drug of choice.

Do not use in cases of resistance against other fluoroquinolones, due to the potential for cross-resistance.  Do not use in dogs under 1 year of age as damage to the articular cartilage may occur during the period of rapid growth, specifically in large breeds of dog. As a precaution very large breeds of dog should not be treated with the product until they are 18 months of age because of their longer growth period.
Do not use in cats less than 8 weeks of age.
Do not use in case of hypersensitivity to the active substance or to any of the excipients.

Special warnings for each target species

Cattle and pigs
None.

Dogs
None.

Cats
Retinotoxic effects including blindness can occur when the recommended dose is exceeded.

 Amounts to be administered and administration route

Cattle:
2.5 mg enrofloxacin per kg bodyweight (0.5ml/10 kg) daily by subcutaneous injection for 3 days. This rate may be doubled to 5 mg enrofloxacin per kg bodyweight (1.0 ml/10 kg) for 5 days for salmonellosis and complicated respiratory diseases.
Not more than 10 ml should be administered at the one subcutaneous injection site.

Pigs (weighing more than 25 kg):
2.5 mg enrofloxacin per kg bodyweight (0.5 ml/10 kg) daily by intramuscular injection for 3 days. This rate may be doubled to 5 mg enrofloxacin per kg bodyweight (1.0 ml/10 kg) for 5 days for salmonellosis and complicated respiratory diseases.
Not more than 2.5 ml should be administered at the one intramuscular site.

Dogs and cats:
5 mg enrofloxacin per kg bodyweight (1.0 ml/10 kg) daily by subcutaneous injection for up to 5 days.  Treatment may be initiated with the injectable product, and maintained with an appropriate oral enrofloxacin product.

To ensure a correct dosage, body weight should be determined as accurately as possible to avoid underdosing.
The vial seal may be punctured up to a maximum of 25 times for the 100 ml vials, or 50 times for the 250ml vials.

Do not exceed the recommended dose. In accidental overdose there is no antidote and treatment should be symptomatic.